Correlation Between Amgen and Shuttle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Amgen and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Amgen and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Shuttle Pharmaceuticals.
Diversification Opportunities for Amgen and Shuttle Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Amgen and Shuttle is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Amgen i.e., Amgen and Shuttle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Amgen and Shuttle Pharmaceuticals
Given the investment horizon of 90 days Amgen Inc is expected to generate 0.22 times more return on investment than Shuttle Pharmaceuticals. However, Amgen Inc is 4.61 times less risky than Shuttle Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 32,789 in Amgen Inc on September 2, 2024 and sell it today you would lose (4,502) from holding Amgen Inc or give up 13.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Amgen Inc vs. Shuttle Pharmaceuticals
Performance |
Timeline |
Amgen Inc |
Shuttle Pharmaceuticals |
Amgen and Shuttle Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amgen and Shuttle Pharmaceuticals
The main advantage of trading using opposite Amgen and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.The idea behind Amgen Inc and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Shuttle Pharmaceuticals vs. Tff Pharmaceuticals | Shuttle Pharmaceuticals vs. Eliem Therapeutics | Shuttle Pharmaceuticals vs. Inhibrx | Shuttle Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |